ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

AstraZeneca at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

AstraZeneca takes part in 11 sessions at ELRIG Drug Discovery 2026 in London, and exhibits at Booth CZ01. Its program centres on AI in drug discovery, gene editing and biophysics. Highlights include templated in vivo editing of disease-causing variants, machine learning in medicinal chemistry and surface plasmon resonance for finding small-molecule tools in compound pools.

OrganizationELRIG Drug Discovery 2026 Attendance
AstraZeneca
Cambridge, UK
◆Partner
Large pharmaPartner
Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.
Booth
Exhibiting at Booth CZ01
Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm
Chair
Wed Oct 14
11:15am–11:20am
Track Chair - CRISPR/Cas technologies from discovery to therapeutic application
How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next.
with The Francis Crick Institute
Chair
Wed Oct 14
11:15am–11:20am
Track Chair - Next-gen biophysics
How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up.
with Domainex
Talk
Wed Oct 14
11:20am–11:50am
From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays
Integrating experimental design, lab-in-the-loop and AI towards translatable discovery
Talk
Wed Oct 14
11:50am–12:20pm
Automating In Vivo Antibody Discovery
How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality.
with Hamilton
Talk
Wed Oct 14
12:20pm–12:50pm
Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance
Next-gen biophysics
Talk
Wed Oct 14
2:40pm–3:10pm
Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands
Targeted potency: Advances in radioligands and bioconjugates
Talk
Wed Oct 14
3:10pm–3:45pm
To PhD or not to PhD? Navigating Life Sciences careers as an ECP
Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers.
Panel
Wed Oct 14
4:30pm–5:00pm
Panel session - The Future of AI and Design of Experiments in Drug Discovery
Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA
Talk
Wed Oct 14
4:30pm–5:00pm
Rewriting Disease-Causing Variants: Templated Editing In Vivo
CRISPR/Cas technologies from discovery to therapeutic application
Talk
Thu Oct 15
12:40pm–1:10pm
The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery
From sample to translation: Solving the practical challenges of modern drug discovery
Talk
Thu Oct 15
3:30pm–4:00pm

Explore the full ELRIG Drug Discovery 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full ELRIG Drug Discovery 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AstraZeneca

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by ELRIG. Submit a correction